“…Subjects covered in recent original papers and reviews in this Weld were the generation and application of speciWc antibodies suited to detect speciWc antigens and/or functional states of macromolecules, glycolipids, advanced glycation end products, and small molecules (e.g., Diamanti-Kandarakis et al 2007;Fujiwara et al 2007;Ohara et al 2007a, b;Schmidt et al 2007;Young et al 2007;Kolling et al 2008;Mandell 2008;Myöhänen et al 2008), the optimization of detection protocols including tissue preparation, improvement of antigen accessibility, and modiWcations of immunocytochemical procedures (Schlormann et al 2007;Blaschitz et al 2008;Takechi et al 2008), the improvement of methods for qualitative and quantitative analyses of the subcellular localization of proteins using immunogold labelling (Bowes et al 2007;Lopez et al 2008;Mayhew and Lucocq 2008a, b), and the quality control in molecular immunohistochemistry (True 2008). In particular, a problem with which the scientist is often confronted in double immunolabelling was addressed in an investigation by Takechi et al (2008): often, the best antibodies available against antigens of interest have been generated in the same species, and thus double labelling appears not applicable at least in indirect immunoXuorescence since cross-reactions of the secondary antibodies will necessarily occur. In their study, the authors developed a protocol for double immunolabelling using rabbit-derived polyclonal antibodies by applying a high dilution for the Wrst antibody so that detectability required biotin-avidin ampliWcation, and by visualizing the second antibody via a standard secondary antibody protocol which was not suYciently sensitive to detect the Wrst antibody.…”